This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Richard Pops, one of the biopharmaceutical industry’s longest-serving chief executives, will step down as the head of Alkermes at the end of July, the company announced Wednesday. Pops will be succeed by Chief Operating Officer Blair Jackson on July 31, Alkermes said. He’ll remain Alkermes’ board chair afterwards and help advise the company’s executive team. ...